Jenburkt Pharmaceuticals Ltd — Board Meeting, 12-05-2025: Board Meeting

Jenburkt Pharmaceuticals Limited has announced a board meeting at its registered office to take on record the audited financial results for the quarter and financial year ended 31st March 2025. The board will also consider the dividend payout, if any. This update signals key financial disclosures that will provide investors with insights into the company’s recent performance and potential returns.